Reverse DCF
What growth does the market imply for AMBUJACEM?
Working backwards from the current price to find the FCF growth assumption baked in.
conservative
6.2% implied annual FCF growth
The market is pricing in below-GDP growth — very conservative assumption. If the company delivers anywhere near its historical rate, there is significant upside.
Current Price
₹410
Historical Growth
4.2%
FCF Yield
4.64%
Price / FCF
21.6x
Plain English
To justify today's price of ₹409.80, AMBUJACEM.NS needs to grow its free cash flow at 6.2% per year for the next 10 years. That is 2.0% faster than its historical growth rate of 4.2%. This looks achievable — the market is not pricing in heroic assumptions. There may be genuine upside if the company executes.
Adjust Assumptions
Growth Scenarios
What the stock is worth at different growth assumptions
| Scenario | FCF Growth | Implied IV | MoS vs Price |
|---|---|---|---|
| Half implied | 3.1% | ₹321 | -21.6% |
| Historical | 4.2% | ₹351 | -14.4% |
| Implied | 6.2% | ₹410 | +0.0% |
| GDP rate | 10.0% | ₹557 | +35.8% |
At Historical Growth Rate
DCF horizon: 10 years. At 4.2% growth, the model values AMBUJACEM at ₹351, below today's ₹410.
See full DCF analysis
Bear/base/bull scenarios, sensitivity heatmap, reverse DCF, and more.
Run Full Analysis →This is an analytical tool, not investment advice. Implied growth is a mathematical inversion of the DCF model and depends on WACC and terminal growth assumptions. YieldIQ is not registered with SEBI as an investment adviser.